These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20948308)

  • 1. Life or death: p53-induced apoptosis requires DNA binding cooperativity.
    Schlereth K; Charles JP; Bretz AC; Stiewe T
    Cell Cycle; 2010 Oct; 9(20):4068-76. PubMed ID: 20948308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functions.
    Schlereth K; Heyl C; Krampitz AM; Mernberger M; Finkernagel F; Scharfe M; Jarek M; Leich E; Rosenwald A; Stiewe T
    PLoS Genet; 2013; 9(8):e1003726. PubMed ID: 23966881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis.
    Schlereth K; Beinoraviciute-Kellner R; Zeitlinger MK; Bretz AC; Sauer M; Charles JP; Vogiatzi F; Leich E; Samans B; Eilers M; Kisker C; Rosenwald A; Stiewe T
    Mol Cell; 2010 May; 38(3):356-68. PubMed ID: 20471942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivo.
    Timofeev O; Schlereth K; Wanzel M; Braun A; Nieswandt B; Pagenstecher A; Rosenwald A; Elsässer HP; Stiewe T
    Cell Rep; 2013 May; 3(5):1512-25. PubMed ID: 23665223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell death machinery governed by the p53 tumor suppressor in response to DNA damage.
    Yoshida K; Miki Y
    Cancer Sci; 2010 Apr; 101(4):831-5. PubMed ID: 20132225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into selective activation of p53 DNA binding by c-Abl.
    Wei G; Li AG; Liu X
    J Biol Chem; 2005 Apr; 280(13):12271-8. PubMed ID: 15661746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiation.
    Chin PL; Momand J; Pfeifer GP
    Oncogene; 1997 Jul; 15(1):87-99. PubMed ID: 9233781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence-dependent sliding kinetics of p53.
    Leith JS; Tafvizi A; Huang F; Uspal WE; Doyle PS; Fersht AR; Mirny LA; van Oijen AM
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16552-7. PubMed ID: 23012405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.
    Kim E; Rohaly G; Heinrichs S; Gimnopoulos D; Meissner H; Deppert W
    Oncogene; 1999 Dec; 18(51):7310-8. PubMed ID: 10602486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role revealed for p53.
    Nat Struct Biol; 1994 Aug; 1(8):487-8. PubMed ID: 7664068
    [No Abstract]   [Full Text] [Related]  

  • 11. PDCD5 functions as a regulator of p53 dynamics in the DNA damage response.
    Zhuge C; Sun X; Chen Y; Lei J
    J Theor Biol; 2016 Jan; 388():1-10. PubMed ID: 26433055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell fate decision mediated by p53 pulses.
    Zhang XP; Liu F; Cheng Z; Wang W
    Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12245-50. PubMed ID: 19617533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53.
    Kim E; Albrechtsen N; Deppert W
    Oncogene; 1997 Aug; 15(7):857-69. PubMed ID: 9266973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of DNA recognition by p53 tetramers.
    Kitayner M; Rozenberg H; Kessler N; Rabinovich D; Shaulov L; Haran TE; Shakked Z
    Mol Cell; 2006 Jun; 22(6):741-753. PubMed ID: 16793544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of p53 with its consensus DNA-binding site.
    Wang Y; Schwedes JF; Parks D; Mann K; Tegtmeyer P
    Mol Cell Biol; 1995 Apr; 15(4):2157-65. PubMed ID: 7891710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 binds to cisplatin-damaged DNA.
    Wetzel CC; Berberich SJ
    Biochim Biophys Acta; 2001 Feb; 1517(3):392-7. PubMed ID: 11342217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of genome-wide p53-binding sites upon stress response.
    Smeenk L; van Heeringen SJ; Koeppel M; van Driel MA; Bartels SJ; Akkers RC; Denissov S; Stunnenberg HG; Lohrum M
    Nucleic Acids Res; 2008 Jun; 36(11):3639-54. PubMed ID: 18474530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression.
    D'Souza S; Xin H; Walter S; Choubey D
    J Biol Chem; 2001 Jan; 276(1):298-305. PubMed ID: 11013253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
    Takimoto R; El-Deiry WS
    Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
    Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
    Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.